Join the Skin and Structure Infection group to help and get support from people like you.
Skin and Structure Infection News
Related terms: Complicated Skin and Skin Structure Infection, cSSSI
FDA Approves Zevtera (ceftobiprole medocaril sodium) for Bacteremia, Skin and Skin Structure Infections, and Pneumonia
Allschwil, Switzerland, April 04, 2024 – Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe...
Factors ID'd That Affect Medical Decision-Making in Hidradenitis Suppurativa
WEDNESDAY, Jan. 17, 2024 – Factors that affect medical decision-making among patients with hidradenitis suppurativa (HS) include suffering threshold, perceptions of treatment risk, treatment...
Barbers Can Partner With Dermatologists to Augment Pseudofolliculitis Barbae Care
MONDAY, Dec. 11, 2023 – An educational intervention targeted at barbers substantially increases knowledge regarding the causes, prevention, and treatment of pseudofolliculitis barbae (PFB),...
Germs Love Two Skin 'Hot Spots' on Your Body
MONDAY, Oct. 2, 2023 – Grandma knew it all along: Certain places on the body are "hot spots" for unhealthy microbes. That notion — which the authors of a new study dubbed “the grandma hypothesis,” af...
Eosinophilic Cellulitis Seems to Be Type 2 Inflammatory Disease
WEDNESDAY, June 21, 2023 – Eosinophilic cellulitis seems to be a type 2 inflammatory disease, with preferential activation of the Janus kinase (JAK)1/JAK2-signal transducer and activator of...
Dalvance (dalbavancin) Receives FDA Approval to Treat Acute Bacterial Skin and Skin Structure Infections in Pediatric Patients
NORTH CHICAGO, Ill., July 23, 2021 /PRNewswire/ – AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) approved Dalvance® (dalbavancin) for the treatment of acute ...
FDA Approves Kimyrsa (oritavancin) for the Treatment of Adult Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
MORRISTOWN, N.J., March 15, 2021 (GLOBE NEWSWIRE) — Melinta Therapeutics, LLC (Melinta), a commercial-stage company focused on the development and commercialization of novel antibiotics, today a...
FDA Approves Nuzyra (omadacycline) for Community-Acquired Bacterial Pneumonia and Acute Skin and Skin Structure Infections
BOSTON, Oct. 02, 2018 (GLOBE NEWSWIRE) – Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) today announced that the U.S. Food and Drug Administration (FDA) has approved Nuzyra (omadacycline) for the...
Melinta Therapeutics Announces FDA Approval of Baxdela (delafloxacin) for Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
NEW HAVEN, Conn, June 19, 2017 – Melinta Therapeutics, a privately held company focused on discovering, developing, and commercializing novel antibiotics to treat serious bacterial infections, a...
Allergan Receives FDA Approval of Teflaro (ceftaroline fosamil) for Pediatric Patients
DUBLIN, May 31, 2016 /PRNewswire/ – Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced the U.S. Food and Drug Administration (FDA) has approved the company's...
Theravance Biopharma Announces FDA Approval of Expanded Label for Vibativ (telavancin)
DUBLIN, IRELAND – (Marketwired) – 05/09/16 – Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that the U.S. Food and Drug Administration (FDA)...
Allergan Announces FDA Approval of Updated Label for New Dosing Regimen for Dalvance (dalbavancin)
DUBLIN, Jan. 21, 2016 /PRNewswire/ – Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced the U.S. Food and Drug Administration (FDA) has approved the company's...
FDA Approves Orbactiv (oritavancin) to Treat Skin and Skin Structure Infections
August 6, 2014 – The U.S. Food and Drug Administration today approved Orbactiv (oritavancin), a new antibacterial drug to treat adults with skin infections. Orbactiv is approved to treat patients...
FDA Medwatch Alert: Cubicin (daptomycin for injection) 500 mg in 10 mL Single Use Vials: Recall - Presence Of Particulate Matter
ISSUE: Cubist Pharmaceuticals, Inc. announced a recall of certain lots of Cubicin (daptomycin for injection) to the user level due to the potential presence of glass particulate matter in vials...
FDA Approves Sivextro (tedizolid phosphate) to Treat Skin Infections
June 20, 2014 – The U.S. Food and Drug Administration today approved Sivextro (tedizolid phosphate), a new antibacterial drug, to treat adults with skin infections. Sivextro is approved to treat...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Related drug support groups
amoxicillin, metronidazole, doxycycline, cephalexin, clindamycin, azithromycin, Cipro, ciprofloxacin, Zithromax, view more... mupirocin, Augmentin, erythromycin, levofloxacin, Bactroban, clarithromycin, sulfamethoxazole / trimethoprim, vancomycin, cefdinir, amoxicillin / clavulanate